NuMe TMS Clinics, providers of Brainsway’s deep TMS (Transcranial Magnetic Stimulation), is pleased to announce that all commercial insurances and Medicare now cover TMS treatment for depression.
The company originated in Boise in early 2017, then moved to Meridian, and now has clinics in Utah and Texas. David Kent, M.D., is the company founder and sole owner. Deep TMS has been FDA approved for the treatment of major depressive and obsessive-compulsive disorders. Kent has also found success in treating PTSD (post-traumatic stress disorder).
Kent offers, “Success rates vary across the country, but NuMe TMS Clinics has seen two out of three patients with depression go into complete remission and another 20 percent get at least a partial response to deep TMS. This is far superior to medication therapies. Research has also determined that TMS has durability. This means that patients can remain symptom-free for much longer periods of time than with other forms of treatment for depression, such as medications or electroconvulsive therapy.”
There are no known long-term side eﬀects with TMS, and it is a targeted approach to specific circuits in the brain. Lead researchers feel TMS works through the principle of neuroplasticity. This refers to the brain’s ability to adapt and, in some cases, heal itself.
Location: 2375 S. Cobalt Wy., Meridian. For more information, visit NuMeTMS.com.